477 related articles for article (PubMed ID: 8937280)
1. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
[TBL] [Abstract][Full Text] [Related]
2. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
Sosa Estani S; Segura EL; Ruiz AM; Velazquez E; Porcel BM; Yampotis C
Am J Trop Med Hyg; 1998 Oct; 59(4):526-9. PubMed ID: 9790423
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
[TBL] [Abstract][Full Text] [Related]
7. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
[TBL] [Abstract][Full Text] [Related]
8. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
[TBL] [Abstract][Full Text] [Related]
9. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.
Andrade AL; Martelli CM; Oliveira RM; Silva SA; Aires AI; Soussumi LM; Covas DT; Silva LS; Andrade JG; Travassos LR; Almeida IC
Am J Trop Med Hyg; 2004 Nov; 71(5):594-7. PubMed ID: 15569790
[TBL] [Abstract][Full Text] [Related]
10. Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras.
Escribà JM; Ponce E; Romero Ade D; Viñas PA; Marchiol A; Bassets G; Palma PP; Lima MA; Zúniga C; Ponce C
Mem Inst Oswaldo Cruz; 2009 Nov; 104(7):986-91. PubMed ID: 20027465
[TBL] [Abstract][Full Text] [Related]
11. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
[TBL] [Abstract][Full Text] [Related]
12. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
[TBL] [Abstract][Full Text] [Related]
13. Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.
Murcia L; Carrilero B; Ferrer F; Roig M; Franco F; Segovia M
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1819-1827. PubMed ID: 27488437
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow up of serological response in children treated for Chagas disease.
Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
[TBL] [Abstract][Full Text] [Related]
15. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
[TBL] [Abstract][Full Text] [Related]
16. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
18. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
19. Chagas' disease: lymphoma growth in rabbits treated with Benznidazole.
Teixeira AR; Córdoba JC; Souto Maior I; Solórzano E
Am J Trop Med Hyg; 1990 Aug; 43(2):146-58. PubMed ID: 2117856
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
